-
1
-
-
75449091572
-
Birth incidence and prevalence of tumor-prone syndromes: Estimates from a UK family genetic register service
-
Evans DG, Howard E, Giblin C, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 2010;152A: 327-332.
-
(2010)
Am J Med Genet A
, vol.152 A
, pp. 327-332
-
-
Evans, D.G.1
Howard, E.2
Giblin, C.3
-
2
-
-
0024456038
-
A genetic study of von Recklinghausen neurofibromatosis in south east Wales: I: Prevalence, fitness, mutation rate, and effect of parental transmission on severity
-
Huson SM, Compston DA, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales: I: prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 1989;26:704-711.
-
(1989)
J Med Genet
, vol.26
, pp. 704-711
-
-
Huson, S.M.1
Compston, D.A.2
Clark, P.3
Harper, P.S.4
-
3
-
-
33847316896
-
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
-
Ferner RE, Huson SM, Thomas N, et al. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 2007;44:81-88.
-
(2007)
J Med Genet
, vol.44
, pp. 81-88
-
-
Ferner, R.E.1
Huson, S.M.2
Thomas, N.3
-
4
-
-
26444599545
-
The nature and frequency of cognitive deficits in children with neurofibromatosis type 1
-
Hyman SL, Shores A, North KN. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 2005;65:1037-1044.
-
(2005)
Neurology
, vol.65
, pp. 1037-1044
-
-
Hyman, S.L.1
Shores, A.2
North, K.N.3
-
5
-
-
47549115330
-
Impact of neurofibromatosis type 1 on school performance
-
Krab LC, Aarsen FK, de Goede-Bolder A, et al. Impact of neurofibromatosis type 1 on school performance. J Child Neurol 2008;23:1002-1010.
-
(2008)
J Child Neurol
, vol.23
, pp. 1002-1010
-
-
Krab, L.C.1
Aarsen, F.K.2
De Goede-Bolder, A.3
-
6
-
-
84872595392
-
Behaviour in children with neurofibromatosis type 1: Cognition, executive function, attention, emotion, and social competence
-
Lehtonen A, Howie E, Trump D, Huson SM. Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence. Dev Med Child Neurol 2013;55:111-125.
-
(2013)
Dev Med Child Neurol
, vol.55
, pp. 111-125
-
-
Lehtonen, A.1
Howie, E.2
Trump, D.3
Huson, S.M.4
-
7
-
-
79952707339
-
Motor learning in children with neurofibromatosis type i
-
Krab LC, de Goede-Bolder A, Aarsen FK, et al. Motor learning in children with neurofibromatosis type I. Cerebellum 2011;10:14-21.
-
(2011)
Cerebellum
, vol.10
, pp. 14-21
-
-
Krab, L.C.1
De Goede-Bolder, A.2
Aarsen, F.K.3
-
8
-
-
27644517404
-
The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1
-
Li W, Cui Y, Kushner SA, et al. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol 2005;15:1961-1967.
-
(2005)
Curr Biol
, vol.15
, pp. 1961-1967
-
-
Li, W.1
Cui, Y.2
Kushner, S.A.3
-
9
-
-
77958498935
-
Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice
-
Brown JA, Emnett RJ, White CR, et al. Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice. Hum Mol Genet 2010; 19:4515-4528.
-
(2010)
Hum Mol Genet
, vol.19
, pp. 4515-4528
-
-
Brown, J.A.1
Emnett, R.J.2
White, C.R.3
-
10
-
-
84878818929
-
Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice
-
Wozniak DF, Diggs-Andrews KA, Conyers S, et al. Motivational disturbances and effects of L-dopa administration in neurofibromatosis-1 model mice. PLoS One 2013;8:e66024.
-
(2013)
PLoS One
, vol.8
, pp. e66024
-
-
Wozniak, D.F.1
Diggs-Andrews, K.A.2
Conyers, S.3
-
11
-
-
84946489244
-
HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1
-
Apr 28
-
Omrani A, Vander Vaart T, Mientjes E, et al. HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1. Mol Psychiatry Epub 2015 Apr 28.
-
(2015)
Mol Psychiatry Epub
-
-
Omrani, A.1
Vander Vaart, T.2
Mientjes, E.3
-
13
-
-
47549111338
-
Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: A randomized controlled trial
-
Krab LC, de Goede-Bolder A, Aarsen FK, et al. Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA 2008;300:287-294.
-
(2008)
JAMA
, vol.300
, pp. 287-294
-
-
Krab, L.C.1
De Goede-Bolder, A.2
Aarsen, F.K.3
-
14
-
-
80052778711
-
Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: Phase i study
-
Acosta MT, Kardel PG, Walsh KS, Rosenbaum KN, Gioia GA, Packer RJ. Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study. Pediatr Neurol 2011;45:241-245.
-
(2011)
Pediatr Neurol
, vol.45
, pp. 241-245
-
-
Acosta, M.T.1
Kardel, P.G.2
Walsh, K.S.3
Rosenbaum, K.N.4
Gioia, G.A.5
Packer, R.J.6
-
15
-
-
84884873014
-
Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1
-
Mainberger F, Jung NH, Zenker M, et al. Lovastatin improves impaired synaptic plasticity and phasic alertness in patients with neurofibromatosis type 1. BMC Neurol 2013;13:131.
-
(2013)
BMC Neurol
, vol.13
, pp. 131
-
-
Mainberger, F.1
Jung, N.H.2
Zenker, M.3
-
16
-
-
84885389443
-
Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): A randomised, placebo-controlled trial
-
Vander Vaart T, Plasschaert E, Rietman AB, et al. Simvastatin for cognitive deficits and behavioural problems in patients with neurofibromatosis type 1 (NF1-SIMCODA): a randomised, placebo-controlled trial. Lancet Neurol 2013;12:1076-1083.
-
(2013)
Lancet Neurol
, vol.12
, pp. 1076-1083
-
-
Vander Vaart, T.1
Plasschaert, E.2
Rietman, A.B.3
-
17
-
-
84991277915
-
The effect of methylphenidate on neurofibromatosis type 1: A randomised, double-blind, placebo-controlled, crossover trial
-
Lion-Francois L, Gueyffier F, Mercier C, et al. The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial. Orphanet J Rare Dis 2014;9:142.
-
(2014)
Orphanet J Rare Dis
, vol.9
, pp. 142
-
-
Lion-Francois, L.1
Gueyffier, F.2
Mercier, C.3
-
18
-
-
0037246371
-
Test reliability and stability of children's cognitive functioning
-
Spencer FH, Bornholt LJ, Ouvrier RA. Test reliability and stability of children's cognitive functioning. J Child Neurol 2003;18:5-11.
-
(2003)
J Child Neurol
, vol.18
, pp. 5-11
-
-
Spencer, F.H.1
Bornholt, L.J.2
Ouvrier, R.A.3
-
19
-
-
60249097471
-
Health-related quality of life in children with neurofibromatosis type 1: Contribution of demographic factors, disease-related factors, and behavior
-
425.e421
-
Krab LC, Oostenbrink R, de Goede-Bolder A, Aarsen FK, Elgersma Y, Moll HA. Health-related quality of life in children with neurofibromatosis type 1: contribution of demographic factors, disease-related factors, and behavior. J Pediatr 2009;154:420-425, 425.e421.
-
(2009)
J Pediatr
, vol.154
, pp. 420-425
-
-
Krab, L.C.1
Oostenbrink, R.2
De Goede-Bolder, A.3
Aarsen, F.K.4
Elgersma, Y.5
Moll, H.A.6
-
20
-
-
0030203845
-
Children and adolescents with neurofibromatosis 1: A behavioral phenotype
-
Dilts CV, Carey JC, Kircher JC, et al. Children and adolescents with neurofibromatosis 1: a behavioral phenotype. J Dev Behav Pediatr 1996;17:229-239.
-
(1996)
J Dev Behav Pediatr
, vol.17
, pp. 229-239
-
-
Dilts, C.V.1
Carey, J.C.2
Kircher, J.C.3
-
21
-
-
84919459048
-
Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1
-
Plasschaert E, Descheemaeker MJ, Van Eylen L, Noens I, Steyaert J, Legius E. Prevalence of autism spectrum disorder symptoms in children with neurofibromatosis type 1. Am J Med Genet B Neuropsychiatr Genet 2015;168B:72-80.
-
(2015)
Am J Med Genet B Neuropsychiatr Genet
, vol.168 B
, pp. 72-80
-
-
Plasschaert, E.1
Descheemaeker, M.J.2
Van Eylen, L.3
Noens, I.4
Steyaert, J.5
Legius, E.6
-
22
-
-
84890771989
-
Neurofibromatosis type 1 and autism spectrum disorder
-
Garg S, Green J, Leadbitter K, et al. Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics 2013;132: e1642-e1648.
-
(2013)
Pediatrics
, vol.132
, pp. e1642-e1648
-
-
Garg, S.1
Green, J.2
Leadbitter, K.3
-
23
-
-
84872586906
-
Autism and other psychiatric comorbidity in neurofibromatosis type 1: Evidence from a population-based study
-
Garg S, Lehtonen A, Huson SM, et al. Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study. Dev Med Child Neurol 2013;55:139-145.
-
(2013)
Dev Med Child Neurol
, vol.55
, pp. 139-145
-
-
Garg, S.1
Lehtonen, A.2
Huson, S.M.3
-
24
-
-
84929963400
-
Autism spectrum disorder profile in neurofibromatosis type i
-
Garg S, Plasschaert E, Descheemaeker MJ, et al. Autism spectrum disorder profile in neurofibromatosis type I. J Autism Dev Disord 2015;45:1649-1657.
-
(2015)
J Autism Dev Disord
, vol.45
, pp. 1649-1657
-
-
Garg, S.1
Plasschaert, E.2
Descheemaeker, M.J.3
-
26
-
-
1642387822
-
Heritability of attention problems in children: Longitudinal results from a study of twins, age 3 to 12
-
Rietveld MJ, Hudziak JJ, Bartels M, van Beijsterveldt CE, Boomsma DI. Heritability of attention problems in children: longitudinal results from a study of twins, age 3 to 12. J Child Psychol Psychiatry 2004;45:577-588.
-
(2004)
J Child Psychol Psychiatry
, vol.45
, pp. 577-588
-
-
Rietveld, M.J.1
Hudziak, J.J.2
Bartels, M.3
Van Beijsterveldt, C.E.4
Boomsma, D.I.5
-
27
-
-
0347746514
-
Long-term stability of the child behavior checklist in a clinical sample of youth with attention deficit hyperactivity disorder
-
Biederman J, Monuteaux MC, Greene RW, Braaten E, Doyle AE, Faraone SV. Long-term stability of the child behavior checklist in a clinical sample of youth with attention deficit hyperactivity disorder. J Clin Child Psychol 2001;30:492-502.
-
(2001)
J Clin Child Psychol
, vol.30
, pp. 492-502
-
-
Biederman, J.1
Monuteaux, M.C.2
Greene, R.W.3
Braaten, E.4
Doyle, A.E.5
Faraone, S.V.6
-
28
-
-
79960461456
-
Assessment of executive function and attention in children with neurofibromatosis type 1: Relationships between cognitive measures and real-world behavior
-
Payne JM, Hyman SL, Shores EA, North KN. Assessment of executive function and attention in children with neurofibromatosis type 1: relationships between cognitive measures and real-world behavior. Child Neuropsychol 2011;17:313-329.
-
(2011)
Child Neuropsychol
, vol.17
, pp. 313-329
-
-
Payne, J.M.1
Hyman, S.L.2
Shores, E.A.3
North, K.N.4
-
29
-
-
84867826988
-
The impact of ADHD on the cognitive and academic functioning of children with NF1
-
Pride NA, Payne JM, North KN. The impact of ADHD on the cognitive and academic functioning of children with NF1. Dev Neuropsychol 2012;37:590-600.
-
(2012)
Dev Neuropsychol
, vol.37
, pp. 590-600
-
-
Pride, N.A.1
Payne, J.M.2
North, K.N.3
-
30
-
-
84875829967
-
Modeling cognitive dysfunction in neurofibromatosis-1
-
Diggs-Andrews KA, Gutmann DH. Modeling cognitive dysfunction in neurofibromatosis-1. Trends Neurosci 2013;36:237-247.
-
(2013)
Trends Neurosci
, vol.36
, pp. 237-247
-
-
Diggs-Andrews, K.A.1
Gutmann, D.H.2
-
31
-
-
84885383491
-
Challenges of cognitive research in neurofibromatosis type 1
-
Acosta MT. Challenges of cognitive research in neurofibromatosis type 1. Lancet Neurol 2013;12:1040-1041.
-
(2013)
Lancet Neurol
, vol.12
, pp. 1040-1041
-
-
Acosta, M.T.1
-
32
-
-
84872299846
-
Paired associate learning in children with neurofibromatosis type 1: Implications for clinical trials
-
Payne JM, Barton B, Shores EA, North KN. Paired associate learning in children with neurofibromatosis type 1: implications for clinical trials. J Neurol 2013;260:214-220.
-
(2013)
J Neurol
, vol.260
, pp. 214-220
-
-
Payne, J.M.1
Barton, B.2
Shores, E.A.3
North, K.N.4
-
33
-
-
77957990320
-
Pilot study of a novel computerized task to assess spatial learning in children and adolescents with neurofibromatosis type 1
-
Ullrich NJ, Ayr L, Leaffer E, Irons MB, Rey-Casserly C. Pilot study of a novel computerized task to assess spatial learning in children and adolescents with neurofibromatosis type 1. J Child Neurol 2010;25:1195-1202.
-
(2010)
J Child Neurol
, vol.25
, pp. 1195-1202
-
-
Ullrich, N.J.1
Ayr, L.2
Leaffer, E.3
Irons, M.B.4
Rey-Casserly, C.5
|